Legal & General Group’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,815
| Closed | -$8K | – | 3507 |
|
|
2020
Q1 | $8K | Sell |
2,815
-1,020
| -27% | -$2.9K | ﹤0.01% | 3212 |
|
|
2019
Q4 | $15K | Hold |
3,835
| – | – | ﹤0.01% | 3245 |
|
|
2019
Q3 | $20K | Hold |
3,835
| – | – | ﹤0.01% | 3140 |
|
|
2019
Q2 | $24K | Sell |
3,835
-408
| -10% | -$2.55K | ﹤0.01% | 3138 |
|
|
2019
Q1 | $30K | Buy |
4,243
+564
| +15% | +$3.99K | ﹤0.01% | 2933 |
|
|
2018
Q4 | $31K | Hold |
3,679
| – | – | ﹤0.01% | 2895 |
|
|
2018
Q3 | $73K | Hold |
3,679
| – | – | ﹤0.01% | 2601 |
|
|
2018
Q2 | $95K | Buy |
3,679
+592
| +19% | +$15.3K | ﹤0.01% | 2517 |
|
|
2018
Q1 | $74K | Sell |
3,087
-758
| -20% | -$18.2K | ﹤0.01% | 2580 |
|
|
2017
Q4 | $132K | Sell |
3,845
-612
| -14% | -$21K | ﹤0.01% | 2470 |
|
|
2017
Q3 | $93K | Buy |
4,457
+911
| +26% | +$19K | ﹤0.01% | 2689 |
|
|
2017
Q2 | $62K | Sell |
3,546
-662
| -16% | -$11.6K | ﹤0.01% | 2846 |
|
|
2017
Q1 | $73K | Sell |
4,208
-42
| -1% | -$729 | ﹤0.01% | 2724 |
|
|
2016
Q4 | $73K | Buy |
4,250
+2,555
| +151% | +$43.9K | ﹤0.01% | 2735 |
|
|
2016
Q3 | $27K | Hold |
1,695
| – | – | ﹤0.01% | 2765 |
|
|
2016
Q2 | $26K | Hold |
1,695
| – | – | ﹤0.01% | 2797 |
|
|
2016
Q1 | $24K | Buy |
+1,695
| New | +$24K | ﹤0.01% | 2642 |
|